341 related articles for article (PubMed ID: 31447771)
1. Gangliosides: Treatment Avenues in Neurodegenerative Disease.
Magistretti PJ; Geisler FH; Schneider JS; Li PA; Fiumelli H; Sipione S
Front Neurol; 2019; 10():859. PubMed ID: 31447771
[TBL] [Abstract][Full Text] [Related]
2. Gangliosides in Neurodegenerative Diseases.
Ledeen R; Chowdhury S
Adv Neurobiol; 2023; 29():391-418. PubMed ID: 36255682
[TBL] [Abstract][Full Text] [Related]
3. Gangliosides in the Brain: Physiology, Pathophysiology and Therapeutic Applications.
Sipione S; Monyror J; Galleguillos D; Steinberg N; Kadam V
Front Neurosci; 2020; 14():572965. PubMed ID: 33117120
[TBL] [Abstract][Full Text] [Related]
4. Gangliosides--a new therapeutic agent against stroke and Alzheimer's disease.
Svennerholm L
Life Sci; 1994; 55(25-26):2125-34. PubMed ID: 7997071
[TBL] [Abstract][Full Text] [Related]
5. A critical role for GM1 ganglioside in the pathophysiology and potential treatment of Parkinson's disease.
Schneider JS
Glycoconj J; 2022 Feb; 39(1):13-26. PubMed ID: 34037912
[TBL] [Abstract][Full Text] [Related]
6. GDNF signaling implemented by GM1 ganglioside; failure in Parkinson's disease and GM1-deficient murine model.
Hadaczek P; Wu G; Sharma N; Ciesielska A; Bankiewicz K; Davidow AL; Lu ZH; Forsayeth J; Ledeen RW
Exp Neurol; 2015 Jan; 263():177-89. PubMed ID: 25448159
[TBL] [Abstract][Full Text] [Related]
7. Gangliosides, α-Synuclein, and Parkinson's Disease.
Ledeen RW; Wu G
Prog Mol Biol Transl Sci; 2018; 156():435-454. PubMed ID: 29747823
[TBL] [Abstract][Full Text] [Related]
8. Monosialogangliosides, neuroprotection, and neuronal repair processes.
Skaper SD; Leon A
J Neurotrauma; 1992 May; 9 Suppl 2():S507-16. PubMed ID: 1613810
[TBL] [Abstract][Full Text] [Related]
9. Impaired ganglioside metabolism in Huntington's disease and neuroprotective role of GM1.
Maglione V; Marchi P; Di Pardo A; Lingrell S; Horkey M; Tidmarsh E; Sipione S
J Neurosci; 2010 Mar; 30(11):4072-80. PubMed ID: 20237277
[TBL] [Abstract][Full Text] [Related]
10. The pathological roles of ganglioside metabolism in Alzheimer's disease: effects of gangliosides on neurogenesis.
Ariga T; Wakade C; Yu RK
Int J Alzheimers Dis; 2011 Jan; 2011():193618. PubMed ID: 21274438
[TBL] [Abstract][Full Text] [Related]
11. GM1 Ganglioside as a Disease-Modifying Therapeutic for Parkinson's Disease: A Multi-Functional Glycosphingolipid That Targets Multiple Parkinson's Disease-Relevant Pathogenic Mechanisms.
Schneider JS
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298133
[TBL] [Abstract][Full Text] [Related]
12. Ganglioside GM1 Targets Astrocytes to Stimulate Cerebral Energy Metabolism.
Finsterwald C; Dias S; Magistretti PJ; Lengacher S
Front Pharmacol; 2021; 12():653842. PubMed ID: 33995070
[TBL] [Abstract][Full Text] [Related]
13. Isolated bovine spinal motoneurons have specific ganglioside antigens recognized by sera from patients with motor neuron disease and motor neuropathy.
Yoshino H; Miyatani N; Saito M; Ariga T; Lugaresi A; Latov N; Kushi Y; Kasama T; Yu RK
J Neurochem; 1992 Nov; 59(5):1684-91. PubMed ID: 1383424
[TBL] [Abstract][Full Text] [Related]
14. GM1 ganglioside administration protects spinal neurons after glutamate excitotoxicity.
Vorwerk CK; Bonheur J; Kreutz MR; Dreyer EB; Laev H
Restor Neurol Neurosci; 1999; 14(1):47-51. PubMed ID: 12671270
[TBL] [Abstract][Full Text] [Related]
15. Interactions of amyloid beta-protein with various gangliosides in raft-like membranes: importance of GM1 ganglioside-bound form as an endogenous seed for Alzheimer amyloid.
Kakio A; Nishimoto S; Yanagisawa K; Kozutsumi Y; Matsuzaki K
Biochemistry; 2002 Jun; 41(23):7385-90. PubMed ID: 12044171
[TBL] [Abstract][Full Text] [Related]
16. Gangliosides and the Treatment of Neurodegenerative Diseases: A Long Italian Tradition.
Fazzari M; Lunghi G; Chiricozzi E; Mauri L; Sonnino S
Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203570
[TBL] [Abstract][Full Text] [Related]
17. Amyloid-β induced toxicity involves ganglioside expression and is sensitive to GM1 neuroprotective action.
Kreutz F; Frozza RL; Breier AC; de Oliveira VA; Horn AP; Pettenuzzo LF; Netto CA; Salbego CG; Trindade VM
Neurochem Int; 2011 Oct; 59(5):648-55. PubMed ID: 21723896
[TBL] [Abstract][Full Text] [Related]
18. Altered distribution of the gangliosides GM1 and GM2 in Alzheimer's disease.
Pernber Z; Blennow K; Bogdanovic N; Månsson JE; Blomqvist M
Dement Geriatr Cogn Disord; 2012; 33(2-3):174-88. PubMed ID: 22572791
[TBL] [Abstract][Full Text] [Related]
19. New Insights on Non-Enzymatic Oxidation of Ganglioside GM1 Using Mass Spectrometry.
Couto D; Melo T; Maciel E; Campos A; Alves E; Guedes S; Domingues MR; Domingues P
J Am Soc Mass Spectrom; 2016 Dec; 27(12):1965-1978. PubMed ID: 27576485
[TBL] [Abstract][Full Text] [Related]
20. Gangliosides and glycolipids in neurodegenerative disorders.
Schneider JS
Adv Neurobiol; 2014; 9():449-61. PubMed ID: 25151391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
